1. Home
  2. BTOC vs ANL Comparison

BTOC vs ANL Comparison

Compare BTOC & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp. Common Stock

N/A

Current Price

$0.61

Market Cap

43.6M

Sector

N/A

ML Signal

N/A

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

N/A

Current Price

$1.45

Market Cap

52.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BTOC
ANL
Founded
2020
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
43.6M
52.0M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
BTOC
ANL
Price
$0.61
$1.45
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
1.4M
10.6K
Earning Date
11-13-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$197,399,541.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.35
N/A
52 Week Low
$0.41
$1.10
52 Week High
$6.18
$2.99

Technical Indicators

Market Signals
Indicator
BTOC
ANL
Relative Strength Index (RSI) 47.63 45.42
Support Level $0.45 $1.32
Resistance Level $0.62 $1.59
Average True Range (ATR) 0.06 0.12
MACD 0.02 0.00
Stochastic Oscillator 85.46 44.83

Price Performance

Historical Comparison
BTOC
ANL

About BTOC Armlogi Holding Corp. Common Stock

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: